Clinical trial
Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of…
NCT00312663 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00312663 |
|---|---|
| Title | Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America |
| Official title | A Phase I/IIa Controlled Study of the Safety, Immunogenicity and Preliminary Efficacy of FMP011/AS01B Candidate Malaria Vaccine in Malaria-naive Adults Living in the United States |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | GlaxoSmithKline Industry The PATH Malaria Vaccine Initiative (MVI) Walter Reed Army Institute of Research (WRAIR) U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum Malaria |
| Intervention type | Biological |
| Interventions | Falciparum Malaria Protein 11 with AS01B adjuvant. |
| Enrollment | 24 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Apr 10, 2006 |
| Last update posted | Nov 26, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: